Mithra Pharmaceuticals SA

About:

Mithra Pharmaceuticals SA specializes in the development of women's health care products.

Website: https://www.mithra.com/en/

Top Investors: Highbridge Capital Management, Armistice Capital, S.R.I.W., Whitebox Advisors

Description:

Mithra Pharmaceuticals SA specializes in the development of women's health care products that are dedicated to the fields of contraception, fertility, and menopause. The two lead development candidates Estelle® (a fifth generation oral contraceptive) and Donesta® (a next generation hormone therapy) are built on Mithra's unique natural estrogen platform, E4 (Estetrol).

Total Funding Amount:

$183M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Liège, Liege, Belgium

Founded Date:

1999-01-01

Founders:

François Fornieri

Number of Employees:

101-250

Last Funding Date:

2024-02-05

IPO Status:

Public

Industries:

© 2025 bioDAO.ai